A Study to Learn About the Study Medicine Called PF-08032562 in People With Advanced or Metastatic Solid Tumors
Pfizer
Pfizer
Fate Therapeutics
Tizona Therapeutics, Inc
M.D. Anderson Cancer Center
Fate Therapeutics
Hoffmann-La Roche
Fate Therapeutics
ISU Abxis Co., Ltd.
Eli Lilly and Company
Masonic Cancer Center, University of Minnesota
Merrimack Pharmaceuticals
Medical University of Vienna